文献速递妇科生殖医学

子宫内膜异位症患者子宫内膜基因表达特征

Gene Expression Signature of Endometrial Samples from Women with and without Endometriosis.
PubMed 文献 · J Minim Invasive Gynecol · 2021-04-08

前瞻性观察队列研究纳入33名女性,比较内异症患者与无内异症对照的子宫内膜分子特征,鉴定出5个下调基因组成的特征,可近乎完美区分内异症组织与无内异症组织(AUC=0.982)。该特征有望成为内异症无创诊断方法。

要点

  • 5个下调基因组成的特征可近乎完美区分内异症与无内异症组织(AUC=0.982)。
  • 该特征基于子宫内膜样本,有望用于内异症的无创诊断。
  • 5折交叉验证可用于真实临床数据生成稳健基因特征。

核心结论

  • 子宫内膜5基因特征可能作为内异症的无创诊断方法。
  • 5折交叉验证的差异基因表达分析方法可用于真实临床数据生成稳健基因特征。

研究设计与样本

  • 前瞻性观察队列研究,纳入33名32-38岁女性,其中内异症组19例,对照组6例,另设8例尸体供者组织验证组。

主要发现

  • 鉴定出5个在内异症患者子宫内膜和异位内膜组织中下调的基因特征。
  • 该特征区分52例内异症组织样本与14例无内异症组织样本的AUC=0.982,MCC=0.832。

关键数值与推荐

  • AUC=0.982,MCC=0.832。

临床怎么用

  • 子宫内膜基因表达特征有望用于内异症的无创诊断。

局限性

  • 样本量较小,对照组仅6例。
  • 需进一步验证该特征在更广泛人群中的诊断效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To develop a prototype of a complex gene expression biomarker for the diagnosis of endometriosis on the basis of differences between the molecular signatures of the endometrium from women with and without endometriosis. DESIGN: Prospective observational cohort study. Evidence obtained from a well-designed, controlled trial without randomization. SETTING: Department of reproductive medicine and surgery, A.I. Evdokimov Moscow State University of Medicine and Dentistry. PATIENTS: A total of 33 women (aged 32-38 years) were included in this study. Patients with and without endometriosis were divided into 2 separate groups. The group composed of patients with endometriosis included 19 living patients with endometriosis who underwent laparoscopic excision of endometriosis. The control group included 6 living patients who underwent laparoscopic excision of incompetent uterine scar after cesarean section, with both surgically and histologically confirmed absence of endometriosis and adenomyosis. An additional control/verification group included various previously RNA-sequencing-profiled tissue samples (endocervix, ovarian surface epithelium) of 8 randomly selected healthy female cadaveric donors aged 32 to 38 years. The exclusion criteria for all patients were hormone therapy and any intrauterine device use for more than 1 year preceding surgery, as well as absence of other diseases of the uterus, fallopian tubes, and ovaries. INTERVENTIONS: Laparoscopic excision of endometriotic foci and hysteroscopy with endometrial sampling were performed. The cadaveric tissue samples included endocervix and ovarian surface epithelium. Endometrial sampling was obtained from the women in the control group. RNA sequencing was performed using Illumina HiSeq 3000 equipment (Illumina, Inc., San Diego, CA) for single-end sequencing. Unique bioinformatics algorithms were developed and validated using experimental and public gene expression datasets. MEASUREMENTS AND MAIN RESULTS: We generated a characteristic signature of 5 genes downregulated in the endometrium and endometriotic tissue of the patients with endometriosis, selected after comparison with the endometrium of the women without endometriosis. This gene signature showed a capacity for nearly perfect separation of all 52 analyzed tissue samples of the patients with endometriosis (endometrial as well as endometriotic samples) from the 14 tissue samples of both living and cadaveric donors without endometriosis (area under the curve = 0.982, Matthews correlation coefficient = 0.832). CONCLUSION: The gene signature of the endometrium identified in this study may potentially serve as a nonsurgical diagnostic method for endometriosis detection. Our data also suggest that the statistical method of 5-fold cross-validation of differential gene expression analysis can be used to generate robust gene signatures using real-world clinical data.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Adamyan L, Aznaurova Y, Stepanian A, et al. Gene Expression Signature of Endometrial Samples from Women with and without Endometriosis. J Minim Invasive Gynecol. 2021. PMID: 33839309. doi:10.1016/j.jmig.2021.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。